MAKING A SAFE AND EFFICACIOUS BREAKTHROUGH IN DISEASE MANAGEMENT

Type 2 Diabetes is a worldwide crisis and comprises ~90% of diabetics. Most anti-diabetic drugs do not act in a glucose-dependent manner and hypoglycemia (extremely low levels of glucose) sometimes occurs. The symptoms are issues such as seizures, unconsciousness, and (rarely) permanent brain damage or death. GPR40 (a receptor highly expressed in the pancreas) is a target which behaves with low hypoglycemia risk.

P11187 is a small molecule NCE which selectively acts on GPR40. This NCE is discovered and developed by PEL’s NCE Research Division. In May 2013 PEL announced the USFDA’s approval for ‘First-in-Human’ P11187 Phase I clinical trials. Currently the Phase I trial is underway and the milestone of ‘First Patient Dosed’ has been achieved.

Click here to know how we are making a difference and are engaged in the search for novel medical solutions through Piramal | Life Sciences.

 

Caring for the communities we operate in

We care for the communities we operate in. Recently in Sri Lanka, Piramal Glass set up a new high capacity Effluent Treatment Plant (ETP) at an investment of USD 190,000. This plant will recycle over 750 cubic meters of water per day to ensure preservation of water and to meet the glass bottle manufacturing requirements.

Our bottle manufacturing is an environment friendly process. Broken Glass (known as “cullet” in the glass industry) is also used as a raw material in the manufacturing process.

The Piramal Glass plant in Sri Lanka annually consumes almost 20,000 tons of broken glass, collected from all parts of the Island at a cost of over USD 760,000. The glass bottle manufacturing plant has a production capacity of 250 tons of glass per day and over 225 million bottles per year. 

Click here to see what we do at Piramal Glass.

Making clean water more accessible

150 million people in India do not yet have access to clean drinking water, and 40 million die due to water borne diseases every year.  We also lose an estimated 73 million working days, erasing USD 600 million in economic value. Sarvajal is a social enterprise that we run to provide an innovative and technology-centric answer to this problem. 

Started in 2009, Sarvajal provides affordable clean drinking water to 100,000 people on a daily basis and provides employment to over 250 people. The price of water per liter is INR 30 paisa (0.006 USD or less). 

At present we run 150 filtration plants including Water ATMs. The water conforms to the international drinking water quality standard, ISO 10500. Two patents for this technological innovation have also been filed.

Sarvajal is one of the many initiatives at Piramal Foundation. Click here to discover the work that we are doing at Piramal Foundation.

The foundation of the Piramal Group

Knowledge

Expertise: We strive for a deeper understanding of our domain. 

Innovation: We aspire to do things creatively.

Action

Entrepreneurship: We are empowered to act decisively and create value. 

Integrity: We are consistent in our thought, speech and action.

Care

Trusteeship: We protect and enhance the interests of our customers, community, employees, partners and shareholders.

​Humility: We aspire to be the best, yet strive to be humble.

 

An anti-ageing cream that works with proof

Lacto Calamine is a product that even celebrated late actor Audrey Hepburn endorsed way back in the 1950s. Today we have spent years in the science labs perfecting an anti-aging cream that actually works and comes with proof of its efficacy.

Lacto Calamine RENEU has a U.S Patented* ULMAe molecule, 9 natural nourishing organic extracts and NAM#, which helps reduce wrinkles and fine lines. Every pack comes with signature ‘proof strips’ to measure the effectiveness of the cream. These proof strips capture the skin’s impressions by measuring the depth of wrinkles and fine lines; and allows comparing the affect over a period of four to eight weeks.

The revolutionary patented formula helps rebuild collagen, reduces wrinkles and fine lines, moisturises the skin and restores the skin’s natural glow. Lacto Calamine is part of the Consumer Products Division at Piramal | Healthcare.
Click here to know more.

Enabling big innovations in healthcare

Decision Resources Group (DRG) provides consultancy to healthcare institutions to create innovations that help them meet their patient’s requirements.

Based in Burlington, Massachusetts (USA), DRG has a pool of over 200 MDs, PhDs, pharmacists, and management professionals who draw insight from a network of 125,000 physicians.  We are primarily focused on providing information products in the bio-pharmaceutical and medical technology sectors, which together represent a USD 2.5 billion market opportunity.

DRG counts 48 of the top 50 global pharmaceutical companies as customers and is proud that many of the biggest names in the global healthcare industry rely on its data, analytics and insights to make critical decisions that affect the future of their business.

Click here to know how businesses use our expertise.